Patents Assigned to Aventis Behring GmbH, a German company
  • Modified factor VIII cDNA
    Publication number: 20020165177
    Abstract: A modified Factor VIII cDNA is described in which the B-domain of the wild-type Factor VIII cDNA has been deleted and a truncated Factor IX intron 1 has been inserted in one or more locatons of the Factor VIII cDNA. Such modified Factor VIII cDNA may be used for a higher yield production of Factor VIII in vitro as well as in a transfervector for gene therapy.
    Type: Application
    Filed: June 15, 2001
    Publication date: November 7, 2002
    Applicant: Aventis Behring GmbH, a German company
    Inventors: Claude Negrier, Jean Luc Plantier